Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.35 |
| ▸ | MGAM | O43451 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.34 |
| ▸ | GMNN | O75496 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | THPO | P40225 | 1/20 | 0.34 |
| ▸ | MTOR | P42345 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL700267 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL17047313 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL17459233 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL9214310 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL2783730 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL11168279 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL5795950 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL15648022 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL21645278 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 | |
| SCHEMBL19435044 | 1.00 | USP2 (0.40) | USP2ALDH1A1CNR1CNR2DNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559577-B2 | Chemical functionalization of cellulosic materials with diazo compounds | Centre National de la Recherche Scientifique—CNRS- (FR) | 2026-02-24 | — | — | US | disclosed |
| US-20230183383-A1 | CHEMICAL FUNCTIONALIZATION OF CELLULOSIC MATERIALS WITH DIAZO COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS - (FR) | 2023-06-15 | — | — | US | disclosed |
| EP-4153638-A1 | CHEMICAL FUNCTIONALIZATION OF CELLULOSIC MATERIALS WITH DIAZO COMPOUNDS | Centre National de la Recherche Scientifique (CNRS) (FR) | 2023-03-29 | — | — | EP | disclosed |
| WO-2021233959-A1 | CHEMICAL FUNCTIONALIZATION OF CELLULOSIC MATERIALS WITH DIAZO COMPOUNDS | UNIVERSITE DE NANTES (FR) | 2021-11-25 | — | — | WO | disclosed |
| EP-3307733-B1 | MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | VERTEX PHARMA (US) | 2021-10-20 | — | — | EP | disclosed |
| CN-107849031-B | Mannose derivatives for the treatment of bacterial infections | 沃泰克斯药物股份有限公司 | 2021-07-27 | — | — | CN | disclosed |
| EP-2900678-B1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | CENTRE NAT RECH SCIENT (FR) | 2020-09-02 | — | — | EP | disclosed |
| CN-111423479-A | Compounds and methods for treating bacterial infections | 华盛顿大学 | 2020-07-17 | — | — | CN | disclosed |
| US-10543223-B2 | Mannose derivatives useful for treating pathologies associated with adherent E. coli | ENTEROME (FR) | 2020-01-28 | — | — | US | disclosed |
| US-10407414-B2 | Mannose derivatives for treating bacterial infections | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2019-09-10 | — | — | US | disclosed |
| US-20180244658-A1 | Mannose Derivatives for Treating Bacterial Infections | VERTEX PHARMACEUTICALS INCORPORATED | 2018-08-30 | — | — | US | disclosed |
| US-20180235991-A1 | MANNOSE DERIVATIVES USEFUL FOR TREATING PATHOLOGIES ASSOCIATED WITH ADHERENT E. COLI | NANTES UNIVERSITE (FR) | 2018-08-23 | — | — | US | disclosed |
| EP-3331893-A1 | MANNOSE DERIVATIVES USEFUL FOR TREATING PATHOLOGIES ASSOCIATED WITH ADHERENT E. COLI | Enterome (FR) | 2018-06-13 | — | — | EP | disclosed |
| EP-3307733-A1 | MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | Vertex Pharmaceuticals Incorporated (US) | 2018-04-18 | — | — | EP | disclosed |
| WO-2017021549-A1 | MANNOSE DERIVATIVES USEFUL FOR TREATING PATHOLOGIES ASSOCIATED WITH ADHERENT E. COLI | ENTEROME (FR) | 2017-02-09 | — | — | WO | disclosed |
| WO-2016199105-A1 | MANNOSE DERIVATIVES FOR TREATING BACTERIAL INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2016-12-15 | — | — | WO | disclosed |
| EP-2900678-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | Centre National de la Recherche Scientifique (C.N.R.S.) (FR) | 2015-08-05 | — | — | EP | disclosed |
| US-20150210781-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | NANTES UNIVERSITE (FR) | 2015-07-30 | — | — | US | disclosed |
| WO-2014016361-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2014-01-30 | — | — | WO | disclosed |
| EP-2690105-A1 | Mannose derivatives, a process for preparing the same and their uses as a drug | Centre National De La Recherche Scientifique (FR) | 2014-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10407414-B2 | Mannose derivatives for treating bacterial infections | MANBA, MAN2A1, MPDU1 | USP2 2963/4885ALDH1A1 2161/4885CNR1 1432/4885 |
| US-20180235991-A1 | MANNOSE DERIVATIVES USEFUL FOR TREATING PATHOLOGIES ASSOCIATED WITH ADHERENT E. COLI | FPR3, CCR3, RXFP3 | USP2 3247/4885ALDH1A1 2484/4885CNR1 322/4885 |
| US-12559577-B2 | Chemical functionalization of cellulosic materials with diazo compounds | ILK, MGAM, LPO | USP2 3117/4885ALDH1A1 663/4885CNR1 3344/4885 |
| US-20180244658-A1 | Mannose Derivatives for Treating Bacterial Infections | MANBA, MAN2A1, MPDU1 | USP2 2963/4885ALDH1A1 2161/4885CNR1 1432/4885 |
| US-10543223-B2 | Mannose derivatives useful for treating pathologies associated with adherent E. coli | FPR3, CCR3, RXFP3 | USP2 3247/4885ALDH1A1 2484/4885CNR1 322/4885 |
| US-20150210781-A1 | MULTIMERIC MANNOSIDES, A PROCESS FOR PREPARING THE SAME AND THEIR USES AS A DRUG | MANBA, MAN2A1, MAN2B2 | USP2 2525/4885ALDH1A1 2762/4885CNR1 2580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.